X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,623,000 | +33.9% | 536,962 | 0.0% | 0.07% | +45.8% |
| Q4 2020 | $3,453,000 | -8.8% | 536,962 | -4.0% | 0.05% | -30.4% |
| Q3 2020 | $3,788,000 | -27.3% | 559,494 | 0.0% | 0.07% | -32.4% |
| Q2 2020 | $5,214,000 | -13.4% | 559,494 | -7.1% | 0.10% | -46.3% |
| Q1 2020 | $6,023,000 | +108.3% | 602,274 | +122.8% | 0.19% | +115.9% |
| Q4 2019 | $2,892,000 | -52.4% | 270,292 | -43.5% | 0.09% | -75.7% |
| Q3 2019 | $6,077,000 | -53.0% | 478,107 | -44.5% | 0.36% | -47.8% |
| Q2 2019 | $12,921,000 | – | 861,393 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |